Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

(2009) V. Ziller et al.   ANNALS OF ONCOLOGY

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12)

(2009) V. H. C. Bramwell et al.   ANNALS OF ONCOLOGY

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

(2009) L. Noens et al.   BLOOD

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

(2009) Sudeep Karve et al.   CURRENT MEDICAL RESEARCH AND OPINION

Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer

(2009) Gretchen Kimmick et al.   JOURNAL OF CLINICAL ONCOLOGY

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

(2008) C McCowan et al.   BRITISH JOURNAL OF CANCER

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival

(2008) J D Wright et al.   BRITISH JOURNAL OF CANCER

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

(2008) Ann H. Partridge et al.   JOURNAL OF CLINICAL ONCOLOGY

Mortality Impact of Less-than-Standard Therapy in Older Breast Cancer Patients

(2007) Marianne Ulcickas Yood et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS